1/93
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
3 layers of tear film
lipid layer (meibomian glands)
aqueous layer (lacrimal glands)
mucous layer (conjunctival goblet cells)
lipid layer
polar phase (binds to lipocalins w/in aqueous layer)
non-polar phase (contain waxes, cholesterol esters, triglycerides)
precent evaporation of aqueous layer
maintain tear film thickness
act as surfactant allowing spread of tear film
deficiency results in evaporative dry eye
aqueous layer function
provide atmospheric oxygen to corneal epithelium
antibacterial activity
wash away debris & noxious stimuli
facilitate transport of leukocytes following injury
optically enhance corneal surface by abolishing minute irregularities
mucous layer
permit wetting
convert corneal epithelium from hydrophobic to hydrophilic
lubrication
deficiency may be feature of both aqueous deficiency & evaporative states
androgens
primarily responsible for regulating lipid production
estrogen receptors
found in conjunctiva & lacrimal glands
progesterone receptors
found in conjunctiva & lacrimal glands
lacrimal glands
stimulate aqueous secretions
goblet cells
stimulate mucus secretion
tear film components are regulated
hormonally & neurally
3 factors required for effective resurfacing of tear film
normal blink reflex
contact between
external ocular surface
eyelids
normal corneal epithelium
dry eye disease
multifactorial disease characterized by loss of homeostasis of tear film and/or ocular surface
DED multifactorial condition characterized by combination of
tear film instability
tear film hyperosmolarity
ocular surface inflammatory
ocular surface damage
neurosensory abnormalities
TFOS DEWS 1
initial landmark study in 2007
standardized global definition & classification
aqueous deficient vs evaporative
TFOS DEWS 2
provided update in 2017
specifically regarding diagnostic & treatment algorithms
stepwise tx based on disease severity
TFOS DEWS 3 (contemporary paradigm)
most recent update in 2025
expansion & increased specificity regarding diagnostic & treatment algorithms
loss of tear-film & ocular surface homeostasis (central concept)
match tx to individual pathogenic driver
classic paradigm
primarily derived from TFOS DEWS 1
aqueous deficient dry eye
evaporative
update w/ TFOS DEWS 2 suggested that majority of pts have mixed dry eye (aqueous deficient & evaporative
aqueous deficient dry eye
sub-type reduction of aqueous component of tears d/t comprised lacrimal gland
evaporative
instability of tear film results in tears inappropriately evaporating from surface
aqueous deficient dry eye can be further sub-divided into
Sjogren Syndrome
Non-sjogren dry eye
Sjogren Syndrome dry eye
autoimmune disease characterized by lymphocytic infiltration of exocrine organs (lacrimal gland, salivary glands)
Non-Sjogren dry eye
lacrimal deficiency
lacrimal gland duct obstruction
reflex block
systemic drugs (antihistamines, anticholinergics, antidepressants/ antipsychotics, beta blockers, diuretics)
antihistamines
reduction of mucosal secretions
anticholinergics
direct inhibition of exocrine gland fluid production
antidepressants/ antipsychotics
strong anticholinergic properties
beta blockers
inhibit beta-adrenoreceptors in tear glands
diuretics
reduction of overall body fluid
lacrimal reflex arc
corneal stimulus → V1 of CN5 → superior salivatory (lacrimal) nucleus CN7 → greater petrosal nerve
evaporative dry eye can be sub-divided into
intrinsic & extrinsic evaporative dry eye
intrinsic evaporative dry eye
internal abnormality which decreases tear evaporation and/or reduces tear film stability
meibomian gland dysfunction
most common
categorized by deficient lipid layer
intrinsic evaporative dry eye
disorders of lid aperatur
specifically, those which result in excessive exposure of ocular surface & incomplete blinking
lagopthalmos, eyelid retraction, ectropion, CN7 palsy, proptosis
intrinsic evaporative dry eye
reduced blink rate
intrinsic evaporative dry eye
Parkinson’s disease, sustained concentration, Botox
extrinsic evaporative dry eye
external factor which increases tear evaporation and/or reduces tear film stability (vitamin A deficiency, contact lens wear, ocular surface disease, environmental exposures)
contemporary paradigm
based off of TFOS DEWS 3 study
classified & identifies based on specific etiological drivers
drivers sprit into tear film deficiencies (composition & quantity), eyelid abnormalities (negatively impacts how tear film is distributed & retained) , ocular surface abnormalities
Ocular surface disease index (OSDI)
12 question pt-reported questionnaire that covers three areas (ocular symptoms, vision related functioning, environmental triggers)
normal score for OSDI
0
severe score of OSDI
100
increased blink rate could indicate
ocular discomfort
compensatory mechanism to refresh tear film more frequently
associated neurological dysfunction
decreased blink rate could indicate
engagement of visually demanding task (most likely to increase evaporative loss)
associated neurological dysfunction
Korb-Blackie Light Test
aka Korb Blackie Lid-leak test
clinical test used to evaluate the quality of the eyelid seal during eyelid closure
ocular staining
diagnostic test utilizing special dyes that highlight damaged or unhealthy areas on surface of the eye
fluorescein dye
primarily evaluates epithelial barrier integrity (superficial cell tight junctions & glycocalyx)
useful for identifying corneal epithelial defects, exposure-related epithelial damage, fluorescein TBUT
considered superior for corneal assessment vs conjunctival assessment
fluorescein tear film breakup time (FTBUT)
interval between complete blink & first dry spot on the cornea after instillation of fluorescein dye
TBUT less than 10 seconds
abnormal tear film stability support diagnosis of DED
TBUT greater than 10 seconds
indicative of tear film stability
noninvasive breakup time
interval between complete blink & first dry spot on the cornea in the absence of fluorescein dye (will have shorter measurements compared to FTBUT)
lissamine green dye
primarily evaluates epithelial cell damage/devitalization irrespective of presence of mucin
lid wiper epitheliopathy
alteration or staining of the marginal conjunctival epithelium of eyelid
occurs secondary to increased friction while blinking between ocular surface & lid wiper
lip wiper
small, thin strip of tissue along inner edge of eyelid
purpose → tear film distribution, protective barrier that reduces friction
rose bengal dye
primarily evaluates mucin/ocular surface protective layer
specifically, stains epithelial cells that are not adequately protected by mucin-rich glycocalyx
tear meniscus height (tear prism height)
measurement of aqueous tear fluid located principally along upper & lower lid margins (indirect measure of tear volume)
Schirmer Test
diagnostic test that measures that quantity of aqueous tears produced by the lacrimal gland during extended period of time
phenol red thread test
minimally invasive diagnostic test that measures the quantity of aqueous tears produced by the lacrimal gland during period of 15 seconds (estimate of tear production)
tear film osmolarity testing
non-invasive objective diagnostic toll used to measure salt concentration of tears
normal tear film osmolarity testing
<308 mOsm/L
abnormal/suggestive of DED of tear film osmolarity testing
>316 mOsm/L
inflammadry
diagnostic testing that aids in identifying ocular surface inflammation
matrix metalloproteinase-9 (MMP-9)
enzyme produced by cells on ocular surface which breaks down components of ECM (also involved in inflammation & tissue remodeling)
meibomian gland expressability
clinical measure of how readily meibum can be expressed from meibomian glands when pressure is applied to the eyelid
Shimazaki expressability score
lower the grade the easier it is expressed and clearer
meibomography
noninvasive imaging technique used to visualize & evaluate structure of meibomian glands in upper & lower eyelids
epithelial thickness map
imaging maps that show thickness & spatial distribution of corneal epithelium across corneal surface
artificial tears
topical ocular lubricants used to supplement or replace natural tear film
low viscosity drops
rapid comfortable lubrication
shorter residence time
useful for mild/intermittent symptoms
higher viscosity drops or gels
longer residence time
provide greater symptomatic relief for moderate to severe dry eye
possibility of transient blurred vision
ointments
provide prolonged lubrication
results in significant blurred vision
lipid containing formulations
help supplement tear-film lipid layer
useful in cases of concomitant meibomian gland dysfunction
preserved artificial tear
advantages: convenient, low risk of microbial contamination after bottle is open
disadvantages: frequent instillation
PFATs
advantages: ideal option for pts w/ significant ocular surface disease & concerns for preservatives sensitivity/toxicity
disadvantages: cost d/t common package (single use vials)
topical corticosteroids mechanism of action
primarily bind to intracellular glucocorticoid receptors thereby altering gene transcription & decreasing inflammatory mediators & immune rxns
potent topical steroids
deep ocular penetration
strong anti-inflammatory effect
higher likelihood for associated risks
soft topical steroids
superficial ocular penetration
weaker anti-inflammatory effect
low likelihood for associated risks
topical immunomodulators: cyclosporine (Restasis, Cequa, VEVYE)
MOA: calcineurin inhibitor that suppress T-cell activation through reduction of IL-2 transcription
targets inflammatory component of dry eye disease
topical pharmaceuticals: liftegrast (Xiidra)
MOA: LFA-1 antagonist inhibitor which prevents immune cells from binding to inflamed ocular surface cells
targets inflammatory component of dry eye disease
ophthalmic semifluorinated alkane class: perfluorohexyloctane ophthalmic solution (MIEBO)
has ability of forming monolayer at air-liquid interface of tear film
only FDA drop approved for evaporative dry eye
lid scrubs
eyelid hygiene that utilizes topical cleansing interventions in hopes of mechanically removing debris and reducing microbial & inflammatory load
mechanical lid exfoliation
aka microblepharoexfoliation, blepharoexfoliation
in-office eyelid hygiene procedure in which controlled mechanical debridement is utilized to clean eyelashes & eyelid margins
used to remove accumulation of epithelial debris, biofilm, collarettes
biofilm
thin, sticky layer of bacteria, oils, & dead skin cells
collarettes
waxy, cylindrical ring of debris that build up at base of eyelashes
warm compresses
external eyelid-heating therapy in which sustained warmth is applied to closed eyelids
intense pulse light (IPL)
controlled light based therapy used to reduced periocular inflammation & improve meibomian gland function
eyelid margin telangiectasia
abnormal, tiny, dilated blood vessels along edge of eyelid (representative of chronic eyelid inflammation)
MiBo ThermoFlo
thermoelectric eyelid-heating & massage system designed to liquefy thickened meibomian gland secretions & facilitate their expression
manual gland expression
procedure used to physically squeeze the meibomian glands to release thickened or blocked meibum
punctal occlusion
intentional obstruction of one or more lacrimal puncta to reduce drainage of tears through nasolacrimal system
punctal occlusion is primarily considered in pts who present w/
reduced tear production
persistent ocular surface dryness
inadequate response to AT
need to increase duration of topical medication on ocular surface
temporary punctal occlusion
often used as a trial before permanent occlusion (absorbable collagen)
semi-permanent/reversible
can be usually be removed if necessary (silicone punctal plugs)
permanent
considered when plugs repeatedly fall out or longer-term occlusion is desired (thermal/cautery punctal occlusion)
scleral lenses
larger diameter, rigid gas permeable contact lens that sits on scleral conjunctiva thereby vaulting over cornea & limbus
PROSE lenses
prosthetic replacement of ocular surface disease
Amniotic Membranes
biologic tissue derived from innermost layer of human placenta used as graft or protective “bandage” thereby facilitating corneal and/or conjunctival healing
five layers of amniotic membranes
amniotic epithelium
basement membrane (similar to BM of cornea & conjunctiva)
compact layer
fibroblast layer
spongy layer